Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Amortizatization of Intangibles: 2016-2024

Historic Amortizatization of Intangibles for Ligand Pharmaceuticals (LGND) over the last 9 years, with Dec 2024 value amounting to $1.3 million.

  • Ligand Pharmaceuticals' Amortizatization of Intangibles rose 869.57% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 221.18%. This contributed to the annual value of $1.3 million for FY2024, which is 0.99% up from last year.
  • Per Ligand Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $1.3 million for FY2024, which was up 0.99% from $1.3 million recorded in FY2023.
  • Ligand Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $1.3 million during FY2024, with a 5-year trough of -$1.5 million in FY2020.
  • Its 3-year average for Amortizatization of Intangibles is $877,667, with a median of $1.3 million in 2023.
  • Per our database at Business Quant, Ligand Pharmaceuticals' Amortizatization of Intangibles plummeted by 114.40% in 2020 and then soared by 8,337.50% in 2023.
  • Yearly analysis of 5 years shows Ligand Pharmaceuticals' Amortizatization of Intangibles stood at -$1.5 million in 2020, then surged by 92.49% to -$111,000 in 2021, then skyrocketed by 85.59% to -$16,000 in 2022, then soared by 8,337.50% to $1.3 million in 2023, then climbed by 0.99% to $1.3 million in 2024.